Mireia Morgades de la Fe

8PUBLICATIONS
96CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 30, 2026
ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.

|May 04, 2026
Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.

|Jan 08, 2025
Preferential Genetic Pathways Lead to Relapses in Adult B-Cell Acute Lymphoblastic Leukemia.

Josgrey Navas-Acosta, Alberto Hernández-Sánchez, Teresa González

|Dec 17, 2024
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups.

Susana Vives, David Quintela, Mireia Morgades

|Dec 19, 2023
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study.

Amir Enshaei, Melvin Joy, Ellie Butler

|Jun 29, 2023
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain.

Anna Torrent, Mireia Morgades, Olga García-Calduch

Pageof 2

Frequent Collaborators

6 joint publications

Josep-Maria Ribera Santasusana

3 joint publications

Jesús-María Hernández-Rivas

2 joint publications

Alberto Orfao

2 joint publications

José-Ángel Raposo-Puglia